Mentions
Extended reach
Total likes
Video views
AI synopsis
Several discussions highlight personal experiences with low-dose Aripiprazole, with one user stating, 'I’ve been more active than I have in years', while another mentions, 'Abilify helped me significantly reduce my PEM.' The tone is generally optimistic, emphasizing phrases like 'game changer' and 'highly effective', indicating a proactive approach to sharing information about potential treatments.
The majority of posts show strong support for the study's findings, with many users sharing personal success stories related to the medication.
Users express high curiosity about the study and its implications, suggesting a significant interest in potential treatments for ME/CFS.
Many discussions delve deep into the medication's effects, dosage, and neuroinflammation, showcasing a thorough consideration of the topic.
Posts convey a strong belief that this study could positively influence treatment protocols for ME/CFS patients.
Should I try Abilify? Off label use of Aripiprazole shows promise as a treatment for ME/CFS: ‘Fifty-seven individuals qualitatively rated the episodes of PEM as milder and shorter in duration and 18 individuals reported a complete resolution of PEM …’ https://t.co/oCLMWine3Y
Off label use of Aripiprazole shows promise as a treatment for #MECFS. Aripiprazole is also known as Abilify. https://t.co/VZalXjtTsF
@renamemecfs Stanford peer reviewed paper on the use of low dose Abilify to treat MECFS. https://t.co/k2TmfGhFZ7
@DrNichtArzt @Arizona10238417 Low-Dose-Aripiprazol wirkt bei mir sehr gut. https://t.co/3zNzzFUVZI
@martinruecker Und warum wurde für Abilify keine Evidenz gefunden wenn es doch eine Studie mit 101 Personen gibt ? Die ist doch mindestens genau so gut wie die zu den ssris die er vorgestellt hat https://t.co/Yzx1r5aI1n
Off label use of Aripiprazole shows promise as a treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): a retrospective study of 101 patients treated with a low dose of Aripiprazole pmc.ncbi.nlm.nih.gov/articles/PMC...
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a challenging illness with unclear origins, but recent studies suggest the brain's inflammation is involved. This video explains three key insights…
The medication treatment of psychoses involves uncertainty. Good recommendations exist for reducing medications, but fears often influence decision-making. This video discusses effective reduction strategies with expert…
@VNoelte12 @DafoeWhitney Stanford peer reviewed paper on the use of low dose Abilify to treat MECFS. https://t.co/k2TmfGhFZ7
@mitchlafon https://t.co/inuFAcEaTp “Off label use of Aripiprazole shows promise as a treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): a retrospective study of 101 patients treated with a low dose of Aripiprazole”
Low-dose aripiprazole (Abilify; LDA) has been a huge win for me. I’ve been more active than I have in years, and I’m having less PEM than ever Here’s the paper on LDA from 2021: https://t.co/hd8Zg5BSjy
@Nayberryk @HopLongCovid @mildTin It’s def not scattered for Abilify either; that’s a very popular tx (Dr. Bonilla at Stanford pretty much tries it on all of us [that & LDN]). There’s a whole FB group dedicated to it too. Many ppl often seem to have dramatic initial responses to Abilify 1/ https://t.co/briEMIZDyH
Have you tried low dose Abilify for your #LongCovid symptoms? Did it reduce your brain fog or neuroinflammation? It has lots of unpleasant side-effects. #medsky www.healthrising.org/blog/2021/03...
RT @JanetDafoe: @renamemecfs Stanford peer reviewed paper on the use of low dose Abilify to treat MECFS. https://t.co/k2TmfGhFZ7
RT @JanetDafoe: @renamemecfs Stanford peer reviewed paper on the use of low dose Abilify to treat MECFS. https://t.co/k2TmfGhFZ7
RT @JanetDafoe: @renamemecfs Stanford peer reviewed paper on the use of low dose Abilify to treat MECFS. https://t.co/k2TmfGhFZ7
RT @JanetDafoe: @renamemecfs Stanford peer reviewed paper on the use of low dose Abilify to treat MECFS. https://t.co/k2TmfGhFZ7
@renamemecfs Stanford peer reviewed paper on the use of low dose Abilify to treat MECFS. https://t.co/k2TmfGhFZ7
@Yrrepmot Some info on LD Abilify... "Off label use of Aripiprazole shows promise as a treatment for Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS): a retrospective study of 101 patients treated with a low dose of Aripiprazole" https://t.co/Um69qgSjiP
@Y0ur_Neighb0ur @alexandrer81988 Here's a link to the small retrospective Stanford study in case it interests you: https://t.co/uIWakTJAqS
@AbyssPearl https://t.co/tUuTKV69Dm
@martinruecker Und warum wurde für Abilify keine Evidenz gefunden wenn es doch eine Studie mit 101 Personen gibt ? Die ist doch mindestens genau so gut wie die zu den ssris die er vorgestellt hat https://t.co/Yzx1r5aI1n
@linds_longcovid @Naomi_D_Harvey Off label use of Aripiprazole shows promise as a treatment for ... (#MECFS): ... https://t.co/UE4aevXmMB "The daily oral dose of aripiprazole ranged from 0.2 to 2.0 mg/day (mean 1.1 mg/day). Dosage started at 0.25 mg/day and titrated up or down" https://t.co/i20kXKhTmZ
@modernainjury @saffronandsky Here is a retrospective study of on the use of LDA: https://t.co/LDs7iFrcmH
@Dfrizz007 https://t.co/XlhQTMbnwQ Have you or your Drs thought about this ? Helped me enormously/ thought to dampen down neuroinflammation
@HashashinTag I don’t think anyone knows yet, as there is really no research about it. There is only one retrospective study, and they have some guesses about it: https://t.co/NOb734mJ1h
@Canal1point5 @TaraFotiPhD Low dose is 0.2 -2mg https://t.co/XlhQTMbnwQ
In case anyone wonders , yes aripiprazole is an antipsychotic. It works in a slightly different way to usual antipsychotics. It balances out dopamine levels in the brain . My response has been just like most in this study https://t.co/XlhQTMbnwQ
@TraceyABurgess @AaronCa11 You’ve probably seen this but : https://t.co/XlhQTMbnwQ
@jacobbiasetti https://t.co/XlhQTMbnwQ
@DrScomaME_CFS Yes, but I thought it was worse than it was. Taking LDA( Aripiprazole) and a lot of my cognitive function has returned. They think it’s dampening down neuroinflammation. https://t.co/XlhQTMbnwQ
@DarrenBar88 https://t.co/XlhQTMbVmo
RT @subversivepsych: Repost/what helped me(along with treating microclots) Off label use of Aripiprazole shows promise as a treatment for M…
Repost/what helped me(along with treating microclots) Off label use of Aripiprazole shows promise as a treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS):a retrospective study of 101 patients treated with a low dose of Aripiprazole https://t.co/XlhQTMbnwQ
Before anyone asks how on earth I’m better enough to be even thinking about employment… doing well on https://t.co/XlhQTMbnwQ
@DebK_hEDS This :-https://t.co/XlhQTMbnwQ And it helping me be more organised to take my other meds most likely . When I was really bad I was just sleeping all the time and forgetting to take meds . I’ve been more religious with my mcas treatment and my anticoagulants for my blood issue
@ThorHessdalen4 @scott_scientist Thank you . https://t.co/XlhQTMbnwQ
RT @subversivepsych: @julia_doubleday This https://t.co/XlhQTMbnwQ
RT @subversivepsych: @Starseeker1986 @smallmercies1 I’m still going much better on https://t.co/XlhQTMbnwQ
@Starseeker1986 @smallmercies1 I’m still going much better on https://t.co/XlhQTMbnwQ
@julia_doubleday This https://t.co/XlhQTMbnwQ
RT @SarahOC_MECFS: @LongCovidKiwi https://t.co/kPpg4IQJ5D
@LongCovidKiwi https://t.co/kPpg4IQJ5D
RT @LongCovidComms: @CovidSolidarit1 @subversivepsych @I_need_a_razor LDA - https://t.co/n3kc5zmF0D
@CovidSolidarit1 @subversivepsych @I_need_a_razor LDA - https://t.co/n3kc5zmF0D
RT @subversivepsych: @AaronCa11 Forward this to your psychiatrist, it has helped me immensely . Our brains are inflamed , this is thought t…
RT @subversivepsych: @tink_ina https://t.co/XlhQTMbVmo This helped me a lot. And I think I had / have an autoimmune encephalitis. Trying t…
@tink_ina https://t.co/XlhQTMbVmo This helped me a lot. And I think I had / have an autoimmune encephalitis. Trying to find somewhere to get testing . In Germany , university of Freiburg seem to be good. There was an article in Science magazine which I’ll try to find. Sorry to hear re
@AaronCa11 Forward this to your psychiatrist, it has helped me immensely . Our brains are inflamed , this is thought to reduce that neuroinflammation. https://t.co/XlhQTMbnwQ
@ThorHessdalen4 Abilify . Low dose abilify has an off licence use in ME. I discovered it the hard way - I knew it was off label for me but for me it was prescribed as my mental health also went . PEM is significantly less , just like those in this small study https://t.co/XlhQTMbnwQ
@nervensystemck @suse1603 @BlondChristina @OnkelHeini3 D2 receptor agonists shown to mediate neuroinflammation, microglial activation…dopamine-modulating aripiprazole may lead to clinical improvement in fatigue & cognitive symptoms in ME/CFS. „not attribute changes in body mass to the use of the medication.“ https://t.co/JWbkXEE7BQ
@nervensystemck Gibt halt Ärzte, die versuchen per Try and Error zu helfen. Zumal es zu LDA mittlerweile ja genügend empirische Erfahrung gibt und das auch in Stanford eingesetzt wird. https://t.co/CNmXTBurHa
@seanstidston
RT @subversivepsych: @annesmithmcc I wish more people could try low dose abilify . I think this has helped me sustain thinking for longer .…
@annesmithmcc I wish more people could try low dose abilify . I think this has helped me sustain thinking for longer . I still crash . But the crashes are not as bad https://t.co/XlhQTMbnwQ
@Annakwood Fatigue too. But it’s definitely lesser . Just like those who did this study reported ( I put my 80% remission down to aripiprazole ) https://t.co/XlhQTMbVmo
@Bettje37 @himmatb15 Low dose aripiprazole https://t.co/XlhQTMbVmo
@gospacecraft @himmatb15 A for aripiprazole https://t.co/XlhQTMbVmo
@MarguliesJohann @AcsenseurSocial Nb: Aripiprazole= abilify, pas de gros risques questions effets secondaires, mais toujours à faire avec un bon suivi et une supervision médicale, go slow and low : a : https://t.co/91gtlzQoQQ B: https://t.co/t43Epdt5Kt
@debbieACSW Part of what helped regulate my sleep ( down ) https://t.co/XlhQTMbnwQ
@NeurologistMom Aripiprazole. It’s totally been a game changer for me https://t.co/XlhQTMbnwQ
RT @subversivepsych: @Micha_von_B Me https://t.co/XlhQTMbVmo
@LizzieKrontiris oh, of course! low-dose abilify >>> https://t.co/laFFAu6PR0
@Emma40025133 https://t.co/XlhQTMbVmo Won’t stop the antibodies but I’ve had a 80% remission with this . Thought to dampen down the inflammation.
@Micha_von_B Me https://t.co/XlhQTMbVmo
@Talmandaniel I’m in a remission using Aripiprazole and it’s so weird …I now get bored where I didn’t before ( was previously bedbound most of the day ) . https://t.co/XlhQTMbVmo
@bubblekittea https://t.co/XlhQTMbVmo Im going well on this . Less PEM , more alert (Hasn’t fixed the blurred vision but 1000mg a day DHA has helped it somewhat )
@elizablue007 Thank you
@zagreusrevival @NZ_fund_MECFS https://t.co/XlhQTMbVmo
@AaronCa11 https://t.co/XlhQTMbVmo
@himmatb15 Yep https://t.co/XlhQTMbVmo
@renudhinakaran Abilify !!! https://t.co/XlhQTMbVmo
https://t.co/XlhQTMbnwQ
@narelleford @ThePOTSPostman Solidarity , that was when I was falling asleep then sleeping all day . Abilify helped me https://t.co/y7sFyJtWfu
@MarekSJF Also developed Hashimoto’s , possible relapsing polychrondritis ( but I think I have that controlled with mcas meds ) cogagulation problems , and ME , ofc . ME doing well with abilify https://t.co/y7sFyJuu52
@I_need_a_razor For your mum and for u. Im 2 months into a remission and I put it down to abilify dampening down neuroinflammation. I also have mental health hx long before long Covid then ME diagnosed 2023. https://t.co/y7sFyJtWfu
@MaryB51630191 https://t.co/XlhQTMbnwQ
@KatBoniface https://t.co/y7sFyJtWfu
@hopefullizzy https://t.co/y7sFyJtWfu
But I’ll take what benefits I can from Anywhere when it comes to the hell that is #ME/CFS Disclaimer / not paid / just a patient trying things. Here is the study https://t.co/XlhQTMbnwQ
@Linusthecat2 https://t.co/XlhQTMbnwQ
RT @subversivepsych: Why I keep on going on about #abilify ( #aripiprazole ) - I *seem* to have imporoved lots - more #energy / PEM isn’t a…
Why I keep on going on about #abilify ( #aripiprazole ) - I *seem* to have imporoved lots - more #energy / PEM isn’t as awful/ slightly less #foggy. I us not a #RCT but .. here we are #MECFS https://t.co/XlhQTMbnwQ
@vijayiyer312 https://t.co/XlhQTMbnwQ
LDA has a retrospective observational study (https://t.co/hEAJ7FtaWf) but the others don't have much evidence in peer-reviewed journals as far as I can tell. Perhaps running a campaign to have LDA approved on the basis of this study could open the door for other drugs
https://t.co/PvfKYoOgBh.
@diannahaze by them . See study . No it’s not a RCT , sadly ..retrospective cohort . But we need everything we can find . My cognition is improved ++ . Sleeping at the right time. Seems to ⬇️neuroinflammation.2/ https://t.co/XlhQTMbnwQ
@gospacecraft Thanks! The doctor prescribing the LDA (low-dose aripiprazole) is a psychiatrist, but he believes that this is a biological illness. So he’s responsible for the treatment. I can link the only study done for it’s use in ME: https://t.co/NOb734mJ1h
Off label use of Aripiprazole shows promise as a treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): a retrospective study of 101 patients treated with a low dose of Aripiprazole pmc.ncbi.nlm.nih.gov/articles/PMC...
@DavidJoffe64 @subversivepsych @ejustin46 Here’s the paper: https://t.co/2gHQZd19Wt
RT @subversivepsych: @DavidJoffe64 @resiapretorius @dbkell @doctorsaluja @DrGrahamLJ @ejustin46 No it’s not a RCT ; however / we don’t have…
@DavidJoffe64 @resiapretorius @dbkell @doctorsaluja @DrGrahamLJ @ejustin46 No it’s not a RCT ; however / we don’t have many options . Long Covid with ME is hell. It’s ok to say that “ this helped me” it’s not like I’m getting paid by the makers of the drug / just trying to help others. https://t.co/XlhQTMbnwQ
Here’s the paper- definitely worth considering as we wait to find out what actually causes the neuroinflammation :- https://t.co/XlhQTMbnwQ 9/
@CovidSolidarit1 https://t.co/XlhQTMbnwQ
https://t.co/XlhQTMbnwQ
@erdbeerforsch also die studie ist zwar nicht double blind aber sieht ziemlich gut aus https://t.co/jNHnpXRiLY Ldn https://t.co/t9EdvbhmF9 Pyridostigmine https://t.co/B02m8mVFb7
Pretty good study on (low dose?) Abilify, FYI! A really high % of ME patients in the study had some type of benefit from it, think I’m gonna give it a go soon. Off label use of Aripiprazole shows promise as a treatment for ME/CFS https://t.co/vUz8zzvRHU
@Lukeholmes11 @scott_scientist You can get dopamine deficiency too. Likely why that other psych drug is trialed. Effects dopamine. https://t.co/9yEUIf9WId
@DavidJoffe64 @gpanger Trying to look for hope…. Looks like he tried IVIG for 3-4 years and also didn’t work…. If I have LC I probably would try SSRI first…. Or Brintellix…. Luckily none of my regular patients have persistent severe long covid... https://t.co/sXabUkA5Xt
RT @gpanger: @Michigan_Noah Someone posted this study - might be worth a look: https://t.co/zTiEFK7Tqv
@OxMEDiscovery https://t.co/0rSzjMzjjM
@drgnfrt @stefkaufman https://t.co/hPZuhG0xDh this is the main paper on it. note that in the second paragraph it mentions the mechanisms of d2 agonists working to lower neuroinflammation. raising dopamine lowers neuroinflammation through a variety of paths. https://t.co/z7zdIUhTHy
@cherylbenson Stanford peer reviewed paper on the use of low dose Abilify to treat MECFS. https://t.co/k2TmfGhFZ7
@MayhemMonza https://t.co/YbMY4E015K Dr. Bonilla at their M.E. Clinic is a co-author: “Off label use of Aripiprazole shows promise as a treatment for ME/CFS: a retrospective study of 101 patients treated with a low dose of Aripiprazole” (low-dose Abilify)
@skinner_lachlan @doyouseem_e_now https://t.co/Ctmdr8Et3C
@Shrink_at_Large Sorry thought you were a psychiatrist from tweet! So Q becomes do you know psychiatrists who would know if can prescribe. https://t.co/BnuBGoCBbf
@Riemerville @doyouseem_e_now @notrendstudio Here’s the paper on it. Easy to read, useful info re dosing, side effects etc. Ppl going to Stanford clinic more recently say they now start lower eg at 0.1mg if pt known to be med sensitive. We started at 0.25 as in the paper. https://t.co/BnuBGoCBbf
RT @LongCovidComms: @mitd_greer https://t.co/n3kc5zncQb
@2laurabone @doyouseem_e_now I saw a small study in ME/CVS - with promising results. Also understand your hesitation. https://t.co/XvwvXVQZSR
@mitd_greer https://t.co/n3kc5zncQb
Oke - beetje eigenwijs. De keuze is toch op Aripiprazole gevallen. Dit voornamelijk - vanwege de herkenning die ik vind in dit onderzoek: https://t.co/XvwvXVRxIp Ik wil over zo'n 3-4 weken starten. Nog iets langer de tijd om mijn huidige baseline na HBOT te bepalen. (1/n) https://t.co/NgV7ZI2Bh0
@taperclinic Lots of folks with Post-COVID/ME started to use LDA (Low Dose Aripiprazol) as an Off-Label medication. The intervention is based on a small study from 2021. Is Aripiprazol (low-dose) a potential candidate for „protracted withdrawal“? https://t.co/Ctmdr8F0Ta
RT @Laughterizbest: @loscharlos Interesting, never heard this before. It's a partial agonist at D2 receptors & 5-HT1A receptors, and antag…
@loscharlos Interesting, never heard this before. It's a partial agonist at D2 receptors & 5-HT1A receptors, and antagonist at 5-HT2A receptors but looks like also lowers IL-1β, IL-6, TNF-α, and IFN-γ. Looks like it also has been study for ME https://t.co/z1fdrhCS9u
@Davemconte Here’s the paper on it. Very short & easy to read. Gives dosing info. https://t.co/BnuBGoCBbf
@MarkMooch @domsalisbury Here’s the paper. Open access. Very short & easy to read. https://t.co/BnuBGoCBbf
RT @MelanieWeckert: Should I try Abilify? Off label use of Aripiprazole shows promise as a treatment for ME/CFS: ‘Fifty-seven individual…
RT @MelanieWeckert: Should I try Abilify? Off label use of Aripiprazole shows promise as a treatment for ME/CFS: ‘Fifty-seven individual…
@dianemteresa @lisaclombardi @bhanlon15 @MelanieWeckert This is quoting this article https://t.co/6rMUbACOln
RT @MelanieWeckert: Should I try Abilify? Off label use of Aripiprazole shows promise as a treatment for ME/CFS: ‘Fifty-seven individual…
RT @MelanieWeckert: Should I try Abilify? Off label use of Aripiprazole shows promise as a treatment for ME/CFS: ‘Fifty-seven individual…
RT @MelanieWeckert: Should I try Abilify? Off label use of Aripiprazole shows promise as a treatment for ME/CFS: ‘Fifty-seven individual…
RT @MelanieWeckert: Should I try Abilify? Off label use of Aripiprazole shows promise as a treatment for ME/CFS: ‘Fifty-seven individual…
RT @MelanieWeckert: Should I try Abilify? Off label use of Aripiprazole shows promise as a treatment for ME/CFS: ‘Fifty-seven individual…
RT @MelanieWeckert: Should I try Abilify? Off label use of Aripiprazole shows promise as a treatment for ME/CFS: ‘Fifty-seven individual…
RT @MelanieWeckert: Should I try Abilify? Off label use of Aripiprazole shows promise as a treatment for ME/CFS: ‘Fifty-seven individual…
RT @MelanieWeckert: Should I try Abilify? Off label use of Aripiprazole shows promise as a treatment for ME/CFS: ‘Fifty-seven individual…
RT @MelanieWeckert: Should I try Abilify? Off label use of Aripiprazole shows promise as a treatment for ME/CFS: ‘Fifty-seven individual…
RT @MelanieWeckert: Should I try Abilify? Off label use of Aripiprazole shows promise as a treatment for ME/CFS: ‘Fifty-seven individual…
Should I try Abilify? Off label use of Aripiprazole shows promise as a treatment for ME/CFS: ‘Fifty-seven individuals qualitatively rated the episodes of PEM as milder and shorter in duration and 18 individuals reported a complete resolution of PEM …’ https://t.co/oCLMWine3Y
Off label use of Aripiprazole shows promise as a treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): a retrospective study of 101 patients treated with a low dose of Aripiprazole | https://t.co/svabK4yyNp https://t.co/cYr4OSEpjP
RT @twoShaws: @gpanger https://t.co/RAJutuS0nT J Transl Med 2021 Feb 3;19(1):50. doi: 10.1186/s12967-021-02721-9 Off label use of Aripipra…
@gpanger https://t.co/RAJutuS0nT J Transl Med 2021 Feb 3;19(1):50. doi: 10.1186/s12967-021-02721-9 Off label use of Aripiprazole shows promise as a treatment for ME/CFS: a retrospective study of 101 patients treated w/ a low dose of Aripiprazole L D Crosby et al.
Off label use of Aripiprazole shows promise as a treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): a retrospective study of 101 patients treated with a low dose of Aripiprazole | Journal of Translational Medicine | Full Text https://t.co/LpAJnb9DO4
@DennisME1893 @BettinaHahn5 @Zett Ich wäre dir wirklich dankbar, wenn du erwähnst, dass du zu Beginn deiner Verbesserung auch mit der Einnahme von Abilify begonnen hast. Mir hat Abilify ebenfalls geholfen und es gibt dazu ja auch bereits eine Studie der Stanford-Uni. https://t.co/m6C8URJbme
RT @Biwe94: @DrNichtArzt @Arizona10238417 Low-Dose-Aripiprazol wirkt bei mir sehr gut. https://t.co/3zNzzFUVZI
RT @Biwe94: @DrNichtArzt @Arizona10238417 Low-Dose-Aripiprazol wirkt bei mir sehr gut. https://t.co/3zNzzFUVZI
RT @Biwe94: @DrNichtArzt @Arizona10238417 Low-Dose-Aripiprazol wirkt bei mir sehr gut. https://t.co/3zNzzFUVZI
RT @Biwe94: @DrNichtArzt @Arizona10238417 Low-Dose-Aripiprazol wirkt bei mir sehr gut. https://t.co/3zNzzFUVZI
@justthore @AimeeValeur Low-Dose-Aripiprazol wirkt bei mir echt gut. https://t.co/3zNzzFUVZI
@DrNichtArzt @Arizona10238417 Low-Dose-Aripiprazol wirkt bei mir sehr gut. https://t.co/3zNzzFUVZI
@EWidera Your missing the point. It’s low dose. Post Covid Conditions (PCC) share many similarities to ME/CFS which we know is post infectious.https://t.co/bLq3tlmRMt Similar to using low dose naltrexone where we use 0.5 -4.5 mg (not 50mg) for pain,fatigue in ME, MS, Long Covid.
RT @ales_frost: @chydorina @saffronandsky @remissionbiome Here's the one study in #MECFS. It definitely doesn't help everyone, but for thos…
@chydorina @saffronandsky @remissionbiome Here's the one study in #MECFS. It definitely doesn't help everyone, but for those of us that it does, it can be extremely helpful https://t.co/3im93BA23d
@51Zuschauer Aripiprazol/Abilify (https://t.co/FQuedJP3vM)
@TimHuttonAu @welcomewords FYI https://t.co/3im93BhSP5
@AmandaB55744931 <1mg dose of Aripiprazole in ME/CFS Off label use of Aripiprazole shows promise as a treatment for ... (ME/CFS): a retrospective study of 101 patients treated with a low dose of Aripiprazole https://t.co/UE4aevFLo1 https://t.co/VCVpV4Xmvl https://t.co/DdRACaXrNe
Off label use of Aripiprazole shows promise as a treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (#MECFS): a retrospective study of 101 patients treated with a low dose of Aripiprazole https://t.co/UE4aevFLo1
@IrishMECFS Off label use of Aripiprazole shows promise as a treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): a retrospective study of 101 patients treated with a low dose of Aripiprazole https://t.co/UE4aevFLo1 https://t.co/VCVpV4Xmvl https://t.co/DdRACaXrNe
Off label use of Aripiprazole shows promise as a treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): a retrospective study of 101 patients treated with a low dose of Aripiprazole | SpringerLink https://t.co/xaGBnhnHrU
@Jim19562 @dianne81659302 @katie_andME Crosby et al. J Transl Med (2021) 19:50 https://t.co/HWfBlfwH83
Off label use of Aripiprazole shows promise as a treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (#MECFS): a retrospective study of 101 patients treated with a low dose of Aripiprazole https://t.co/UE4aevFLo1
RT @speeckx: Off label use of Aripiprazole shows promise as a treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): a…
Off label use of Aripiprazole shows promise as a treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): a retrospective study of 101 patients treated with a low dose of Aripiprazole | Journal of Translational Medicine | Full Text https://t.co/YVoqFLTWYs
7. Publisher Correction to: Off label use of Aripiprazole shows promise as a treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): a retrospective study of 101 patients treated with a low dose of Aripiprazole. https://t.co/PJ5pv7Y32O
RT @AmmesAdmin: Research: Off label use of Aripiprazole shows promise as a treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome…
RT @AmmesAdmin: Research: Off label use of Aripiprazole shows promise as a treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome…
RT @AmmesAdmin: Research: Off label use of Aripiprazole shows promise as a treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome…
RT @AmmesAdmin: Research: Off label use of Aripiprazole shows promise as a treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome…
RT @AmmesAdmin: Research: Off label use of Aripiprazole shows promise as a treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome…
RT @AmmesAdmin: Research: Off label use of Aripiprazole shows promise as a treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome…
RT @AmmesAdmin: Research: Off label use of Aripiprazole shows promise as a treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome…
RT @AmmesAdmin: Research: Off label use of Aripiprazole shows promise as a treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome…
Research: Off label use of Aripiprazole shows promise as a treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): a retrospective study of 101 patients treated with a low dose of Aripiprazole. https://t.co/XpNztEbRft #MECFS
Publisher Correction to: Off label use of Aripiprazole shows promise as a treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): a retrospective study of 101 patients treated with a low dose of Aripiprazole https://t.co/0s2NhPAXbS
RT @arisonsned: Off label use of Aripiprazole shows promise as a treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS):…
RT @arisonsned: Off label use of Aripiprazole shows promise as a treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS):…
RT @arisonsned: Off label use of Aripiprazole shows promise as a treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS):…
Off label use of Aripiprazole shows promise as a treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): a retrospective study of 101 patients treated with a low dose of Aripiprazole https://t.co/RDs8oF5xl3
"Off label use of Aripiprazole shows promise as a treatment for ME/CFS: a retrospective study of 101 patients treated with a low dose of Aripiprazole" by Bonilla et al. https://t.co/DRMlAdVdw8 6/11
RT @MECFSNews: Off label use of Aripiprazole shows promise as a treatment for #MECFS. Aripiprazole is also known as Abilify. https://t.co/V…
mt #translational Off label use of Aripiprazole shows promise as a treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): a retrospective study of 101 patients treated with a low dose of Aripiprazole… https://t.co/et3Xs55hY3, see more https://t.co/n3pMIRVV53
RT @MECFSNews: Off label use of Aripiprazole shows promise as a treatment for #MECFS. Aripiprazole is also known as Abilify. https://t.co/V…
RT @MECFSNews: Off label use of Aripiprazole shows promise as a treatment for #MECFS. Aripiprazole is also known as Abilify. https://t.co/V…
RT @Invest_in_ME: Crosby et al. Off label use of Aripiprazole shows promise as a treatment for #MECFS): a retrospective study of 101 patien…
RT @MECFSNews: Off label use of Aripiprazole shows promise as a treatment for #MECFS. Aripiprazole is also known as Abilify. https://t.co/V…
RT @MECFSNews: Off label use of Aripiprazole shows promise as a treatment for #MECFS. Aripiprazole is also known as Abilify. https://t.co/V…
Off label use of Aripiprazole shows promise as a treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): a retrospective study of 101 patients treated with a low dose of Aripiprazole #MEartikler https://t.co/BRZx2kl9eO
RT @MECFSNews: Off label use of Aripiprazole shows promise as a treatment for #MECFS. Aripiprazole is also known as Abilify. https://t.co/V…
RT @MECFSNews: Off label use of Aripiprazole shows promise as a treatment for #MECFS. Aripiprazole is also known as Abilify. https://t.co/V…
RT @MECFSNews: Off label use of Aripiprazole shows promise as a treatment for #MECFS. Aripiprazole is also known as Abilify. https://t.co/V…
RT @MECFSNews: Off label use of Aripiprazole shows promise as a treatment for #MECFS. Aripiprazole is also known as Abilify. https://t.co/V…
RT @Invest_in_ME: Crosby et al. Off label use of Aripiprazole shows promise as a treatment for #MECFS): a retrospective study of 101 patien…
RT @MECFSNews: Off label use of Aripiprazole shows promise as a treatment for #MECFS. Aripiprazole is also known as Abilify. https://t.co/V…
RT @MECFSNews: Off label use of Aripiprazole shows promise as a treatment for #MECFS. Aripiprazole is also known as Abilify. https://t.co/V…
RT @MECFSNews: Off label use of Aripiprazole shows promise as a treatment for #MECFS. Aripiprazole is also known as Abilify. https://t.co/V…
RT @MECFSNews: Off label use of Aripiprazole shows promise as a treatment for #MECFS. Aripiprazole is also known as Abilify. https://t.co/V…
RT @MECFSNews: Off label use of Aripiprazole shows promise as a treatment for #MECFS. Aripiprazole is also known as Abilify. https://t.co/V…
RT @MECFSNews: Off label use of Aripiprazole shows promise as a treatment for #MECFS. Aripiprazole is also known as Abilify. https://t.co/V…
RT @MECFSNews: Off label use of Aripiprazole shows promise as a treatment for #MECFS. Aripiprazole is also known as Abilify. https://t.co/V…
RT @Invest_in_ME: Crosby et al. Off label use of Aripiprazole shows promise as a treatment for #MECFS): a retrospective study of 101 patien…
Off label use of Aripiprazole shows promise as a treatment for #MECFS. Aripiprazole is also known as Abilify. https://t.co/VZalXjtTsF
Crosby et al. Off label use of Aripiprazole shows promise as a treatment for #MECFS): a retrospective study of 101 patients treated with a low dose of Aripiprazole. https://t.co/K8jLLIFaTf
DM
MN
JD
MP
A
MS
DC
N
P
AB
EV
YU
LB
NW
RS
J
DL
NS
AG
SB
CO
SC
SC
LC
H
TJ
PU
I
AM
E
MR
YL
EC
KC
AT
TA
ᵉᴘ
DF
TC
A
S
CP
BB
CM
A
R
MG
B
BH
JN
?
MG
G
JM
TB
PF
K
HT
C
A
PA
RS
S
NW
VC
KD
R
TR
A
P
JK
P
A
SI
DC
FM
M
RK
DC
IM
EV
A
M
TT
G
A
SF
IA
B
FS
E
SR
TC
VJ
VV
TD
LS
LM
MS
ᴇE
MB
IM
TK
CC
LM
IR